Of note, SGLT2 inhibitors also reduce cardiovascular mortality or hospitalization for heart failure, thus showing benefits across the cardiorenal axis
Could the pleiotropic effects of GLP-1 drugs on multiple organ systems change how we think about treating obesity-related comorbidities as a whole
10.1038/nature03649 70 LeeJ
Although the symptoms of neurodegenerative disorders vary, all of them present with progressive neuronal degeneration in specific brain regions (Jellinger, 2010)
ROS are produced by multiple intrinsic mechanisms, and ROS come in a variety of forms, including radical (hydroxyl, superoxide, etc.) or non-radical (hydrogen peroxide, singlet oxygen, etc.) [25]